Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Patrick M. Travis being referenced

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial
2021
Effect of adding ublituximab to ibrutinib on PFS, ORR, and MRD negativity in previously treated high-risk chronic lymphocytic leukemia: Final results of the GENUINE phase III study.
2020

Author Peers

Author Last Decade Papers Cites
Patrick M. Travis 50 27 51 343 228 10 472
A. Price 47 5 31 188 184 14 502
Isabelle Gauthier 14 15 110 295 274 11 569
H. Selim 105 10 21 369 283 12 483
Tanja Pelz 35 19 162 149 153 16 547
Yenting Ngai 40 14 29 376 268 17 544
P. Dickinson 31 9 62 203 205 21 456
Virag Dandekar 26 25 24 151 233 6 520
Patrick Cavanaugh 39 7 115 162 251 16 554
T. Yu 49 4 24 272 265 12 480
P. B. Kunkler 29 7 48 203 100 15 531

All Works

Loading papers...

Rankless by CCL
2026